Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel

Clinical trial NCT03392051 · COMPLETED

Trial details

NCT number: NCT03392051
Sponsor: Akcea Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Elevated Lipoprotein(a)Cardiovascular Diseases

Start date: 2017-12-28
Primary completion: 2018-03-18
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.